Bamco Inc. NY Has $14.10 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP

Bamco Inc. NY decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 61.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 190,023 shares of the company’s stock after selling 301,729 shares during the quarter. Bamco Inc. NY owned about 0.65% of Inspire Medical Systems worth $14,100,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Texas Permanent School Fund Corp boosted its position in shares of Inspire Medical Systems by 42.2% in the second quarter. Texas Permanent School Fund Corp now owns 40,042 shares of the company’s stock valued at $5,196,000 after acquiring an additional 11,892 shares during the period. Y Intercept Hong Kong Ltd increased its position in Inspire Medical Systems by 553.1% during the third quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company’s stock worth $7,349,000 after acquiring an additional 83,883 shares during the period. CW Advisors LLC increased its position in Inspire Medical Systems by 45.3% during the second quarter. CW Advisors LLC now owns 49,960 shares of the company’s stock worth $6,484,000 after acquiring an additional 15,576 shares during the period. Illinois Municipal Retirement Fund raised its stake in Inspire Medical Systems by 262.0% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 25,424 shares of the company’s stock valued at $1,886,000 after purchasing an additional 18,400 shares during the last quarter. Finally, Capital Fund Management S.A. boosted its holdings in Inspire Medical Systems by 44.1% in the 2nd quarter. Capital Fund Management S.A. now owns 68,663 shares of the company’s stock valued at $8,910,000 after purchasing an additional 21,021 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of INSP stock opened at $58.64 on Monday. The firm has a fifty day moving average of $73.86 and a 200-day moving average of $85.96. The stock has a market cap of $1.68 billion, a price-to-earnings ratio of 11.77, a P/E/G ratio of 2.90 and a beta of 0.74. Inspire Medical Systems, Inc. has a 52-week low of $53.11 and a 52-week high of $172.95.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Wednesday, February 11th. The company reported $1.65 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.96. The business had revenue of $269.08 million for the quarter, compared to analyst estimates of $264.02 million. Inspire Medical Systems had a net margin of 15.95% and a return on equity of 10.96%. The firm’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.15 EPS. On average, sell-side analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. UBS Group set a $67.00 price target on shares of Inspire Medical Systems in a research report on Friday, February 13th. Wells Fargo & Company set a $70.00 target price on shares of Inspire Medical Systems and gave the company an “equal weight” rating in a research note on Thursday, February 12th. Weiss Ratings reissued a “sell (d)” rating on shares of Inspire Medical Systems in a research report on Monday, December 29th. Wolfe Research lowered Inspire Medical Systems from an “outperform” rating to a “peer perform” rating in a research note on Friday, February 13th. Finally, Evercore reaffirmed an “outperform” rating on shares of Inspire Medical Systems in a report on Friday, February 27th. Five investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $104.24.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.